- Home
- ERH vs FBIO Comparison
ERH vs FBIO Comparison
Compare ERH & FBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ERH
- FBIO
- Stock Information
- Founded
- ERH 2004
- FBIO 2006
- Country
- ERH United States
- FBIO United States
- Employees
- ERH N/A
- FBIO N/A
- Industry
- ERH Finance/Investors Services
- FBIO Biotechnology: Pharmaceutical Preparations
- Sector
- ERH Finance
- FBIO Health Care
- Exchange
- ERH Nasdaq
- FBIO Nasdaq
- Market Cap
- ERH 108.0M
- FBIO 88.7M
- IPO Year
- ERH N/A
- FBIO N/A
- Fundamental
- Price
- ERH $12.66
- FBIO $2.73
- Analyst Decision
- ERH
- FBIO Strong Buy
- Analyst Count
- ERH 0
- FBIO 2
- Target Price
- ERH N/A
- FBIO $16.50
- AVG Volume (30 Days)
- ERH 23.2K
- FBIO 1.5M
- Earning Date
- ERH 01-01-0001
- FBIO 11-13-2025
- Dividend Yield
- ERH 8.85%
- FBIO N/A
- EPS Growth
- ERH N/A
- FBIO N/A
- EPS
- ERH N/A
- FBIO N/A
- Revenue
- ERH N/A
- FBIO $59,301,000.00
- Revenue This Year
- ERH N/A
- FBIO $31.85
- Revenue Next Year
- ERH N/A
- FBIO $44.43
- P/E Ratio
- ERH N/A
- FBIO N/A
- Revenue Growth
- ERH N/A
- FBIO N/A
- 52 Week Low
- ERH $7.97
- FBIO $1.33
- 52 Week High
- ERH $10.91
- FBIO $4.20
- Technical
- Relative Strength Index (RSI)
- ERH 62.42
- FBIO 40.50
- Support Level
- ERH $12.01
- FBIO $2.72
- Resistance Level
- ERH $13.07
- FBIO $2.83
- Average True Range (ATR)
- ERH 0.17
- FBIO 0.26
- MACD
- ERH 0.02
- FBIO -0.16
- Stochastic Oscillator
- ERH 59.62
- FBIO 8.70
About ERH Allspring Utilities and High Income Fund
Allspring Utilities and High Income Fund is a diversified closed-end management investment company. Its investment objective is to seek a high level of current income and moderate capital growth, with an emphasis on providing tax-advantaged dividend income. The company allocates a majority of its total assets to a sleeve that places a focus on common, preferred, and convertible preferred stocks of utility companies and the rest of its total assets to a sleeve of U.S. dollar denominated below investment grade (high yield) debt.
About FBIO Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.